FDA shortage - Cerezyme (imiglucerase)

Cerezyme (imiglucerase) Injection Shortage
Please see the following information about the current Cerezyme supply shortage as well as information about alternate therapies for Gaucher patients.

Dear Doctor letter
http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM176861.pdf

Dear Patient letter
http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM176864.pdf

Request Form
http://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM176875.pdf

Genzyme Corporation contact information: Genzyme Medical Information: medinfo@genzyme.com or 1-800-745-4447, option 2

Please see the web sites listed below for additional information:

Genzyme supply update
http://supplyupdate.genzyme.com/

Treatment Protocol of Velaglucerase Alfa
http://www.clinicaltrials.gov/ct2/show/NCT00954460?term=velaglucerase&rank

Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease
http://www.clinicaltrials.gov/ct2/show/NCT00962260?term=prgcd